Suchergebnisse

Using The White Paper (by which the EU has been trying to help the CEEC countries to bring their legislative activities in line with the EU regulation), the author looks into the regulation of genetically modified (GM) products & the ways in which risks from GM products can be minimized. The essay includes a review of the existing regulations & an analysis of the changes in the political & economic circumstances that require the corresponding changes in the existing by-laws. The prime movers in the arena in which the GM products policy is designed are scattered intercontinentally: the multinational corporations of the US agro-industrial complex, the individual farmers & their associations on both sides of the Atlantic, & the European agro-industrial businesses & governments. The disagreement among these protagonists was made apparent during the process preceding the adoption of the Protocol on Bio-Security, envisaged as the framework for the new regulation. The communique of the EU Commission as a sequel to the Cartagena Protocol on Bio-Security illustrates the EU's approach to the application of the caution principle, which is particularly appropriate in the situations in which science is not able to take in all the risks connected with the GM products. The process of the modification of the EU regulation on GM products is an indication of the complexity of the interests involved. This is the reason the process has not been completed. However, this does not justify the delay in the launching of this process in Croatia, which could use the regulation of other countries, briefly summarized at the end of the essay. Adapted from the source document.